These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2212804)

  • 1. [Effect of danazol on bone mineral content and bone metabolism in patients with endometriosis].
    Ohta H; Nemoto K; Nozawa S; Tamura S; Iizuka R
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Jul; 42(7):675-81. PubMed ID: 2212804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Danazol and its effect on bone and lipid metabolism in patients with endometriosis].
    Duque G; Bianchi M; Fernández C; Arteaga E
    Rev Chil Obstet Ginecol; 1995; 60(1):34-7. PubMed ID: 8525034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mass in endometriosis patients treated with GnRH agonist implant or danazol.
    Dodin S; Lemay A; Maheux R; Dumont M; Turcot-Lemay L
    Obstet Gynecol; 1991 Mar; 77(3):410-5. PubMed ID: 1825135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low-dose danazol therapy in endometriosis].
    Furuya K; Murakami M; Mizumoto Y; Tokuoka S; Makimura N; Nagata I
    Nihon Rinsho; 2001 Jan; 59 Suppl 1():145-51. PubMed ID: 11235154
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormonal therapies for endometriosis: implications for bone metabolism.
    Dawood MY
    Acta Obstet Gynecol Scand Suppl; 1994; 159():22-34. PubMed ID: 8209669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in bone mineral content following hormone treatment for endometriosis.
    Fukushima M
    Int J Gynaecol Obstet; 1995 Sep; 50 Suppl 1():S17-22. PubMed ID: 8529770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in bone mineral content and bone metabolism related to menopause].
    Ohta H; Nemoto K; Nozawa S; Iizuka R
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1447-54. PubMed ID: 2584821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis.
    Ylikorkala O; Nilsson CG; Hirvonen E; Viinikka L
    Gynecol Endocrinol; 1990 Dec; 4(4):251-60. PubMed ID: 2150580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danazol in the treatment of endometriosis and infertility.
    Dmowski WP
    Prog Clin Biol Res; 1982; 112 Pt B():167-86. PubMed ID: 6819580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone and mineral metabolism in the adult guinea pig: long-term effects of estrogen and androgen deficiency.
    Vanderschueren D; Van Herck E; Suiker AM; Allewaert K; Visser WJ; Geusens P; Bouillon R
    J Bone Miner Res; 1992 Dec; 7(12):1407-15. PubMed ID: 1481727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group.
    Rock JA; Truglia JA; Caplan RJ
    Obstet Gynecol; 1993 Aug; 82(2):198-205. PubMed ID: 8336864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Age-dependent decrease in plasma androgens, and role of androgens in bone mineral density and bone metabolism].
    Adachi M; Takayanagi R
    Clin Calcium; 2006 Mar; 16(3):419-27. PubMed ID: 16508123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer.
    Cottreau CM; Ness RB; Modugno F; Allen GO; Goodman MT
    Clin Cancer Res; 2003 Nov; 9(14):5142-4. PubMed ID: 14613992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone treatment related bone mineral content changes in Japanese women with endometriosis.
    Fukushima M; Shindo M; Sato K
    Asia Oceania J Obstet Gynaecol; 1993 Sep; 19(3):299-307. PubMed ID: 8250765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of danazol on serum lipid and lipoprotein levels in patients with endometriosis].
    Fukuda Y; Tamura S
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jun; 39(6):980-6. PubMed ID: 3611874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical application of luteinizing hormone releasing hormone agonist and its impact on bone metabolism].
    Zhang M; He Y; Cao S
    Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):398-401. PubMed ID: 7587574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on endocrine therapy of endometriosis].
    Terakawa N
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Aug; 41(8):981-9; discussion 1000-7. PubMed ID: 2530291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotropin-releasing hormone agonist and danazol.
    Dawood MY; Lewis V; Ramos J
    Fertil Steril; 1989 Jul; 52(1):21-6. PubMed ID: 2501109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial.
    Henzl MR; Corson SL; Moghissi K; Buttram VC; Berqvist C; Jacobson J
    N Engl J Med; 1988 Feb; 318(8):485-9. PubMed ID: 2963213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.